Veru to Participate in the Cantor Oncology, Hematology & HemeOnc Conference on September 28th, 2022

September 21, 2022

https://www.globenewswire.com/news-release/2022/09/21/2520175/11676/en/Veru-to-Participate-in-the-Cantor-Oncology-Hematology-HemeOnc-Conference-on-September-28th-2022.html

MIAMI, Sept. 21, 2022 (GLOBE NEWSWIRE) — Veru Inc. (NASDAQ:VERU), a biopharmaceutical company focused on developing novel medicines for COVID-19 and other viral and ARDS-related diseases and for the management of breast and prostate cancers, today announced that the Company will participate in the Cantor Oncology, Hematology, HemeOnc Conference to be held at the Lotte New York Palace in New York City on Wednesday, September 28, 2022.

Read more at globenewswire.com

Related news for (VERU)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.